The immunobiology and clinical characteristics of IgG4 related diseases

Journal of Autoimmunity

Volumn 39, Issue 1-2, 2012, Pages 93-96

  Takahashi, Hiroki ^a   Yamamoto, Motohisa ^a   Tabeya, Tetsuya ^a   Suzuki, Chisako ^a   Naishiro, Yasuyoshi ^a   Shinomura, Yasuhisa ^a   Imai, Kohzoh ^b  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Autoimmune pancreatitis; IgG4 related disease; Mikulicz's disease; Saxon's test; Sj gren's syndrome

Indexed keywords

AUTOANTIBODY; CORTICOSTEROID; IMMUNOGLOBULIN G4;

ADOLESCENT; ADULT; AGED; ARTHRALGIA; ARTICLE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; FEMALE; HUMAN; HYPERGAMMAGLOBULINEMIA; IMMUNOBIOLOGY; KIDNEY; LACRIMAL GLAND; LUNG; MAJOR CLINICAL STUDY; MALE; MIKULICZ DISEASE; PANCREAS; PRIORITY JOURNAL; PROGNOSIS; RASH; RETROPERITONEUM; RETROSPECTIVE STUDY; SALIVARY GLAND; SJOEGREN SYNDROME; SWELLING;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; FEMALE; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN G; LACRIMAL APPARATUS; MALE; MIDDLE AGED; MIKULICZ' DISEASE; PANCREATITIS; RETROSPECTIVE STUDIES; SALIVARY GLANDS; SJOGREN'S SYNDROME; YOUNG ADULT;

EID: 84862489395     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.01.007     Document Type: Article

References (21)

1. Mikulicz J. Uber eine eigenartige symmetrishe Erkrankung der Tranen und Mundspeicheldrusen 1892, Stuttgart: Beitr. z. Chir. Fesrschr. f. Theodor Billroth, pp. 610-30.
2. Yamamoto M., Harada S., Ohara M., Suzuki C., Naishiro Y., Yamamoto H., et al. Clinical and pathological differences between Mikulicz's disease and Sjögren's Syndrome. Rheumatology (Oxford) 2005, 44:227-234.
3. Yamamoto M., Harada S., Ohara M., Suzuki C., Naishiro Y., Yamamoto H., et al. Beneficial effects of steroid therapy for Mikulicz's disease. Rheumatology 2005, 44:1322-1323.
4. Takahashi H., Yamamoto M., Suzuki C., Naishiro Y., Shinomura Y., Imai K. Autoimmun Rev 2010, 9:591-594.
5. Okazaki K., Kawa S., Kamisawa T., Naruse S., Tanaka S., Nishimori I., et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 2006, 41:626-631.
6. Shimosegawa T., Chari S.T., Frulloni L., Kamisawa T., Kawa S., Mino-Kenudson M., et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2010, 40:352-358.
7. Fujibayashi T., Sugai S., Miyasaka N., Hayashi Y., Tsubota K. Revised Japanese criteria for Sjögren's syndrome (1999): availability and validity. Mod Rheumatol 2004, 14:425-434.
8. Yamamoto M., Takahashi H., Shinomura Y. Mikulicz's disease and its extraglandular lesions. Curr Immunol Rev 2011, 7:162-171.
9. Kohler P.F., Winter M.E. A quantitative test for xerostomia. Arthritis Rheum 1985, 28:1128-1132.
10. Anaya J.-M., Talal N. Sjögren's syndrome and connective tissue diseases associated with other immunologic disorders. Arthritis and allied condition 1997, 1561-1580. Williams & Wilkins, Pennsylvania. 13th ed. W.J. Koopman (Ed.).
11. Morgan W.S., Castleman B. A clinicopathologic study of "Mikulicz's disease.". Amer J Pathol 1953, 29:471-503.
12. Harrison J.D., Rodriguez-Justo M. Commentary on IgG4-related sialadenitis: Mikulicz's disease, Kuttner's tumour, and eponymy. Histopathology 2011, 58:1164-1166.
13. Vaglio A., Palmisano A., Alberici F., Maggiore U., Ferretti S., Cobelli R., et al. Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet 2011, 378:338-346.
14. Saeki T., Nishi S., Imai N., Ito T., Yamazaki H., Kawano M., et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int 2010, 78:1016-1023.
15. Fauchais A.L., Martel C., Gondran G., Lambert M., Launay D., Jauberteau M.O., et al. Immunologcal profile in primary Sjögren's syndrome. Clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmun Rev 2010, 9:595-599.
16. Baimpa E., Dahabreh I.J., Voulgarelis M., Moutsopoulous H.M. Hematologic manifestations and predictors of lymphoma development in primary Sjögren's syndrome. Medicine 2009, 88:284-293.
17. Ramos-Casals M., Solans R., Rosas J., Teresa M., Gil A., Pino-Montes J., et al. Primary Sjögren's syndrome in Spain. Clinical and immunologic expression in 1010 patients. Medicine 2008, 87:210-219.
18. Afzelius P., Fallentin E.M., Larsen S., Moller S., Schiodt M. Pancreatic function and morphology in Sjögren's syndrome. Scand J Rheumatol 2010, 45:752-758.
19. Suga K., Kawakami Y., Hiyama A., Hori K., Takeuchi M. F-18 FDG-PET finding in Mikulicz's disease and systemic involvement of IgG4-related lesions. Clin Nucl Med 2009, 34:164-167.
20. Fox P.C., Datiles M., Atkinson J.C., Macynski A.A., Scott J., Fletcher D., et al. Prednisone and piroxicam for treatment of primary Sjögren's syndrome. Clin Exp Rheumatol 1993, 11:149-156.
21. Miyawaki S., Nishiyama S., Matoba K. Efficacy of low-dose prednisone maintenance for saliva production and serological abnormalities in patients with primary Sjögren's syndrome. Intern Med 1999, 38:938-943.